Form 4 holding
Director
Candel Therapeutics, Inc.
- Security class
- Common Stock
- Shares / value
- 283,514
- Estimated value
- $1,550,821
- Report date
- 25 Jun 2025
- Price
- $5.47
- Ownership
- By GTAM1 2012 ADV LLC
Christopher Martell - Director at Candel Therapeutics, Inc.
Issuer-level insider activity
- Role
- Director
- Issuer ticker
- CADL on Nasdaq
- Entity type
- Individual
- Source filing history
- Open source filing history
Identity
Names, identifiers, and filing context for this profile.
1 identity field
Source evidence
Original filing metadata and source links for verification.
1 source field
No buys or sells have been reported by Christopher Martell since 20 Aug 2025
Reported holdings for Christopher Martell in Candel Therapeutics, Inc.
Form 4 holding
Director
Candel Therapeutics, Inc.
- Security class
- Common Stock
- Shares / value
- 152,000
- Estimated value
- $831,440
- Report date
- 25 Jun 2025
- Price
- $5.47
- Ownership
- By GTAM1 2012 LLC
Form 4 holding
Director
Candel Therapeutics, Inc.
- Security class
- Common Stock
- Shares / value
- 111,349
- Estimated value
- $519,999
- Report date
- 25 Jun 2025
- Price
- $4.67
- Ownership
- By Spouse
Form 4 holding
Director
Candel Therapeutics, Inc.
- Security class
- Stock Option (Right to Buy)
- Shares / value
- 32,000
- Estimated value
- Report date
- 23 Jun 2026
- Price
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
Transaction history for Christopher Martell in Candel Therapeutics, Inc.
| Sym | Class | Transaction | % | SEC-reported value | SEC-reported price | Shares | Shares after | Date | Ownership |
|---|
* marks a reported price that did not pass the local price check.